JNJ vs MRK
By Alex · Tickerpine
Johnson & Johnson vs Merck & Co., Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | MRK |
|---|---|---|
| Price | $285.75 | $147.76 |
| Market cap | $687.89B | $364.26B |
| P/E ratio | 43.4 | 149.3 |
| ROE | 20.02% | 5.06% |
| Profit margin | 16.20% | 3.64% |
| Revenue growth | 5.90% | 4.70% |
| Dividend yield | 1.88% | 2.30% |
| Beta | 0.20 | 0.12 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs MRK in plain English
- JNJ is the bigger company — about 1.9× the market cap of MRK.
- JNJ is cheaper on earnings (P/E 43.4 vs 149.3).
- JNJ earns a higher return on equity (20% vs 5%).
- JNJ is growing revenue faster (6% vs 5%).
- MRK has the higher dividend yield (2.30% vs 1.88%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.